Case Study | EU registration of a Biosimilar

July 19, 2022

Have a look at a recent success story of how Asphalion achieved Marketing authorization for a biosimilar medicine for a company located in East Asia that wanted to access the EU market.

Thanks to our extensive track record of over 20 year at Asphalion we can assist you with your all CMC activities, non-CMC specific ones and with all other kind of projects.

CLICK HERE TO SEE THE CASE STUDY IN DETAIL

For further information you can contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

PragmaTIL | Second Annual Meeting

Asphalion expert Núria García participated last week in the 2nd Annual PragmaTIL Consortium Meeting in Amsterdam, hosted by the Netherlands Cancer Institute (NKI). This two-day

EVENT | RAPS EuroConvergence 2025

At ASPHALION we are pleased to announce our participation in RAPS EuroConvergence 2025, one of the premier regulatory affairs events in Europe. This year’s conference

ARDAT | General Assembly Meeting in Barcelona

Last week, ARDAT project members gathered in Barcelona for the project’s General Assembly. The ARDAT project is focused on accelerating the research and development of

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting